ACM
ZBH icon

Aster Capital Management’s Zimmer Biomet ZBH Stock Holding History

Aster Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-262
Closed -$29.7K – 1300
2026
Q1 		$29.7K Buy
+262
New +$24K 0.01% 511
2025
Q1 		– Sell
-4,745
Closed -$501K – 1715
2024
Q4 		$501K Buy
4,745
+4,660
+5,482% +$500K 0.19% 143
2024
Q3 		$9.18K Buy
+85
New +$9.28K ﹤0.01% 823

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aster Capital Management's ZBH Position: Q2 2026 in Review

Aster Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 262 shares — an estimated $29.7K sold.

Aster Capital Management first reported a position in ZBH in Q3 2024 and held it in 3 quarters. The position peaked at $501K in Q4 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Aster Capital Management reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 262 Zimmer Biomet shares in Q2 2026, an estimated $29.7K.
  • Aster Capital Management first reported a position in Zimmer Biomet in Q3 2024 and held it in 3 quarters.
  • Aster Capital Management's Zimmer Biomet position peaked at $501K in Q4 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.